September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a ...
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia ...
January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology ...
January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the ...
August 5, 2011 — BridgePoint Medical Inc., a Minnesota-based medical device company, has enrolled its first patient in ...
May 19, 2011 - BridgePoint Medical Inc. has announced that they have received clearance of an expanded indication for ...
October 5, 2010 – A U.S. clinical study evaluating the CrossBoss and Stingray catheters in treating chronically occluded ...
November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral ...
March 13, 2009 - BridgePoint Medical Inc. completed the first human clinical case in the U.S. using its CrossBoss CTO ...